Hypertension commonly co-exists with obstructive sleep apnea (OSA). However, the role of renin-angiotensin-aldosterone system (RAAS) in the development of hypertension in OSA patients remains poorly ...

Overweight children are more vulnerable to early-onset hypertension. Childhood obesity is driving a rise in high blood ...

SGLT2 inhibitor use is associated with a reduced risk of hyperkalemia and lower rates of renin-angiotensin-aldosterone system ...

SGLT2 inhibitors may enable continuation of RAAS inhibitors for hypertension treatment, which is linked with better kidney and cardiovascular outcomes.

Renal hypoperfusion occurs as a result of reduced cardiac output, resulting in the activation of the renin–angiotensin–aldosterone system, which compensates for the hypoperfusion. However ...

SGLT2 Inhibitors Linked to Lower Hyperkalemia Risk and Improved RAASi Continuation suggests a new study published in the JAMA ...

The Diabetes Injection Pens Market is expected to witness a growth rate of ~7% by 2028. The key factors driving the market ...

Hypertension, commonly known as high blood pressure, is a major risk factor for cardiovascular diseases. It affects millions ...

(NBC News) In a large study of diabetes, heart failure, or chronic kidney disease patients on renin-angiotensin-aldosterone system (RAAS) inhibitors, starting an SGLT2 inhibitor was associated ...

High blood pressure frequently occurs in people with diabetes. Learn about the relationship, risks, and treatments for ...

The novel aldosterone inhibitor works, but longer-term safety data are needed before the drug might be approved.

Therapy should include either belimumab or a calcineurin inhibitor, plus one or more conventional medications such as ...